🔎 Trials Near Me

Gara Jalqabaatti › Kansarii Epithelial Ovarii › Tennessee

Qorannoo klinikaalii Kansarii Epithelial Ovarii Tennessee keessatti

Qorannoo 6 Kansarii Epithelial Ovarii f Tennessee keessatti hirmaatuu jiru.

Magaalota Tennessee keessatti

Takkalaa qorannoo (Ingiliffa)

Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer

  • Erlanger Health, Chattanooga
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Dubartoota · Haaromfame 05-Onk-2026 · NCT06915025

Whole Body Metabolic Activity as a Reflection of Tumor Metabolic Dysregulation and a Predictor of Treatment Response in Ovarian Cancer

  • University of Tennessee Medical Center - Knoxville, Knoxville
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Dubartoota · Haaromfame 17-Hag-2026 · NCT07764133

AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer

  • Research Site, Germantown
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Dubartoota · Haaromfame 21-Ado-2026 · NCT07218809

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

  • Sarah Cannon Research Institute (Oncology Associates of Oregon PC), Nashville
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Dubartoota · Haaromfame 02-Ado-2026 · NCT06819007

CT-95 in Advanced Cancers Associated With Mesothelin Expression

  • Context Investigational Site, Nashville
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 12-Wax-2026 · NCT06756035

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

  • Vanderbilt University Medical Center, Nashville
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Hag-2025 · NCT04429542

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.